BetterLife Pharma Inc. BETR
CNSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.51M | -1.37M | -1.08M | -1.32M | -585.80K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 987.10K | 63.30K | -243.60K | -568.20K | -1.03M |
| Change in Net Operating Assets | 23.00K | 693.80K | 869.60K | 1.73M | 1.36M |
| Cash from Operations | -1.50M | -616.50K | -452.00K | -157.50K | -252.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 2.39M | 411.00K | 411.00K | 25.00K | 25.00K |
| Total Debt Repaid | -11.50K | -8.20K | -5.00K | -1.80K | -- |
| Issuance of Common Stock | 659.00K | 456.50K | 223.20K | 183.70K | 218.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 2.18M | 622.90K | 454.50K | 149.80K | 176.30K |
| Foreign Exchange rate Adjustments | 100.00 | 400.00 | 300.00 | -100.00 | 300.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 681.70K | 7.10K | 3.00K | -7.70K | -76.30K |